PCS6422 and capecitabine
PCS6422-GI-01
Phase 1 small_molecule completed
Quick answer
PCS6422 and capecitabine for Advanced Cancer is a Phase 1 program (small_molecule) at Processa Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Processa Pharmaceuticals
- Indication
- Advanced Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed